Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically ...
Breadcrumb Trail Links GlobeNewswire Author of the article: Published Nov 13, 2024 • 2 minute read Article content ST. LOUIS, Nov. 13, 2024 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, announced today that its ECLIPSE trial met its …